Literature DB >> 11289080

Lipophilicity in PK design: methyl, ethyl, futile.

H van de Waterbeemd1, D A Smith, B C Jones.   

Abstract

Lipophilicity, often expressed as distribution coefficients (log D) in octanol/water, is an important physicochemical parameter influencing processes such as oral absorption, brain uptake and various pharmacokinetic (PK) properties. Increasing log D values increases oral absorption, plasma protein binding and volume of distribution. However, more lipophilic compounds also become more vulnerable to P450 metabolism, leading to higher clearance. Molecular size and hydrogen bonding capacity are two other properties often considered as important for membrane permeation and pharmacokinetics. Interrelationships among these physicochemical properties are discussed. Increasing size (molecular weight) often gives higher potency, but inevitably also leads to either higher lipophilicity, and hence poorer dissolution/solubility, or to more hydrogen bonding capacity, which limits oral absorption. Differences in optimal properties between gastrointestinal absorption and uptake into the brain are addressed. Special attention is given to the desired lipophilicity of CNS drugs. In examples using beta-blockers, Ca channel antagonists and peptidic renin inhibitors we will demonstrate how potency and pharmacokinetic properties need to be balanced.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289080     DOI: 10.1023/a:1008192010023

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

1.  Blood-brain barrier permeation: molecular parameters governing passive diffusion.

Authors:  H Fischer; R Gottschlich; A Seelig
Journal:  J Membr Biol       Date:  1998-10-01       Impact factor: 1.843

2.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics.

Authors:  U Norinder; P Sjöberg; T Osterberg
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

3.  Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.

Authors:  K Palm; K Luthman; A L Ungell; G Strandlund; F Beigi; P Lundahl; P Artursson
Journal:  J Med Chem       Date:  1998-12-31       Impact factor: 7.446

4.  Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics.

Authors:  U Norinder; T Osterberg; P Artursson
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

Review 5.  The functional role of P-glycoprotein in the blood-brain barrier.

Authors:  J van Asperen; U Mayer; O van Tellingen; J H Beijnen
Journal:  J Pharm Sci       Date:  1997-08       Impact factor: 3.534

6.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

7.  Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors.

Authors:  H W Hamilton; B A Steinbaugh; B H Stewart; O H Chan; H L Schmid; R Schroeder; M J Ryan; J Keiser; M D Taylor; C J Blankley
Journal:  J Med Chem       Date:  1995-04-28       Impact factor: 7.446

8.  P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

Authors:  H Spahn-Langguth; G Baktir; A Radschuweit; A Okyar; B Terhaag; P Ader; A Hanafy; P Langguth
Journal:  Int J Clin Pharmacol Ther       Date:  1998-01       Impact factor: 1.366

9.  Computation of brain-blood partitioning of organic solutes via free energy calculations.

Authors:  F Lombardo; J F Blake; W J Curatolo
Journal:  J Med Chem       Date:  1996-11-22       Impact factor: 7.446

10.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

Authors:  S Winiwarter; N M Bonham; F Ax; A Hallberg; H Lennernäs; A Karlén
Journal:  J Med Chem       Date:  1998-12-03       Impact factor: 7.446

View more
  40 in total

Review 1.  Do drug metabolism and pharmacokinetic departments make any contribution to drug discovery?

Authors:  Dennis Smith; Esther Schmid; Barry Jones
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values.

Authors:  Mario Lobell; Vinothini Sivarajah
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

3.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.

Authors:  Travis T Wager; Ramalakshmi Y Chandrasekaran; Xinjun Hou; Matthew D Troutman; Patrick R Verhoest; Anabella Villalobos; Yvonne Will
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

4.  Correlation of elimination fraction area under the curve with total body clearance.

Authors:  Tomasz Grabowski; Anna Raczyńska-Pawelec; Marcin Starościak; Jerzy Jan Jaroszewski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-14       Impact factor: 2.441

Review 5.  A review of imaging agent development.

Authors:  Eric D Agdeppa; Mary E Spilker
Journal:  AAPS J       Date:  2009-05-05       Impact factor: 4.009

Review 6.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

7.  Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.

Authors:  Lauri Peura; Kalle Malmioja; Kristiina Huttunen; Jukka Leppänen; Miia Hämäläinen; Markus M Forsberg; Mikko Gynther; Jarkko Rautio; Krista Laine
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

8.  Estimation of biliary excretion of foreign compounds using properties of molecular structure.

Authors:  Mohsen Sharifi; Taravat Ghafourian
Journal:  AAPS J       Date:  2013-11-08       Impact factor: 4.009

Review 9.  Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.

Authors:  Karin R Tietje; David J Anderson; R Scott Bitner; Eric A Blomme; Paul J Brackemeyer; Clark A Briggs; Kaitlin E Browman; Dagmar Bury; Peter Curzon; Karla U Drescher; Jennifer M Frost; Ryan M Fryer; Gerard B Fox; Jens Halvard Gronlien; Monika Håkerud; Earl J Gubbins; Sabine Halm; Richard Harris; Rosalind J Helfrich; Kathy L Kohlhaas; Devalina Law; John Malysz; Kennan C Marsh; Ruth L Martin; Michael D Meyer; Angela L Molesky; Arthur L Nikkel; Stephani Otte; Liping Pan; Pamela S Puttfarcken; Richard J Radek; Holly M Robb; Eva Spies; Kirsten Thorin-Hagene; Jeffrey F Waring; Hilde Ween; Hongyu Xu; Murali Gopalakrishnan; William H Bunnelle
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

10.  The Flip-Flop Diffusion Mechanism across Lipids in a Hybrid Bilayer Membrane.

Authors:  Christopher J Barile; Edmund C M Tse; Ying Li; John P Gewargis; Nicholas A Kirchschlager; Steven C Zimmerman; Andrew A Gewirth
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.